ArticleFoods (Basel, Switzerland)2026
Immobilization of β-Agarase onto Ni-NTA Magnetic Nanoparticles for Efficient Production of Functional Neoagarooligosaccharides.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
AgaDcat is a promising β-agarase for the production of functional neoagarooligosaccharides (NAOSs), but its limited thermal stability and poor reusability as a free enzyme increase enzyme consumption and production cost during repeated agarose hydrolysis. In this study, β-agarase AgaDcat was immobilized on nickel-nitrilotriacetic acid magnetic nanoparticles (Ni-NTA-MNPs) through His-tag/Ni-NTA affinity interactions. The successful preparation of Ni-NTA-MNPs and the immobilization of AgaDcat were verified by SEM, EDS, VSM, FT-IR, XRD, and TGA. Following optimization, the immobilized enzyme exhibited an activity retention of 80.47%. Thermal stability assays showed that the immobilized enzyme was more thermostable than the free enzyme. After incubation at 50 °C for 60 min, the immobilized enzyme retained 59.4% of its initial activity, whereas the free enzyme retained only 29.1%. Moreover, the immobilized enzyme displayed good reusability, retaining 90.59% and 58.71% of its activity after 3 and 7 cycles, respectively. HPAEC-PAD analysis showed that the immobilized enzyme reached reaction equilibrium within 4-8 h, with neoagarotetraose (NA4) and neoagarohexaose (NA6) identified as the major degradation products, whereas the free enzyme required 20 h, indicating significantly improved catalytic efficiency. These results indicate that IMAC-based immobilization improves the stability, reusability, and catalytic efficiency of β-agarase, providing a promising reusable biocatalytic strategy for the efficient production of functional neoagarooligosaccharides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.